Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 292 Records) |
Query Trace: FGFR1[original query] |
---|
Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 354-362. Wang Zechen, Anderson Karen |
Genetic spectrum of Kallmann syndrome: Single-center experience and systematic review. Clinical endocrinology 2022 9 97 (6): 804-813. Patil Virendra A, Lila Anurag Ranjan, Shah Nalini, Arya Sneha, Sarathi Vijaya, Shah Ravikumar, Jadhav Swati S, Memon Saba Samad, Karlekar Manjiri, Bandgar Tush |
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race. The oncologist 2022 Aug . Zimmerman Raquel, Bilen Mehmet A, Heath Elisabeth I, Nandagopal Lakshminarayanan, Swami Umang, Kessel Adam, Jaeger Ellen, Wesolowski Sergiusz, Hernanadez Edgar J, Chipman Jonathan, Mack Alleda, Ravindranathan Deepak, Maughan Benjamin L, Nussenzveig Roberto, Yandell Mark, Kohli Manish, Lilly Michael B, Sartor A Oliver, Agarwal Neeraj, Barata Pedro |
Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
Significant association between FGFR1 mutation frequency and age in central giant cell granuloma. Pathology 2022 11 . Niada Stefania, Varazzani Andrea, Giannasi Chiara, Fusco Nicola, Armiraglio Elisabetta, Di Bernardo Andrea, Cherchi Alessandro, Baj Alessandro, Corradi Domenico, Tafuni Alessandro, Parafioriti Antonina, Ferrero Stefano, Bianchi Andrea Edoardo, Giannì Aldo Bruno, Poli Tito, Latif Farida, Brini Anna Tere |
Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatric dermatology 2023 7 . Kelly K Barry, Marilyn G Liang, Daniel M Balkin, Siddharth Srivastava, Alanna J Church, Whitney E |
Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia. Cancer genetics 2023 7 276-277 43-47. Lisa M Marinelli, Joshua T Romain, William Ehman, Veronica Ortega, Gopalrao Velagaleti, Thomas F Gibbons, Ashley Nazario-Toole, Allen R Holm |
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia 2023 7 . Georgia Metzgeroth, Laurenz Steiner, Nicole Naumann, Johannes Lübke, Sebastian Kreil, Alice Fabarius, Claudia Haferlach, Torsten Haferlach, Wolf-Karsten Hofmann, Nicholas C P Cross, Juliana Schwaab, Andreas Reit |
Ethnic Differences in the Brazilian Population Influence the Impact of BMP4 Genetic Variants on Susceptibility of Nonsyndromic Orofacial Clefts. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2023 6 10556656231180086. Lilianny Querino Rocha de Oliveira, Hellen Carolliny de Souza Nicolau, Daniella Reis Barbosa Martelli, Hercílio Martelli-Júnior, Rafaela Scariot, Ana Lúcia Carrinho Ayroza Rangel, Silvia Regina de Almeida Reis, Ricardo D Coletta, Renato Assis Macha |
Genetic Influence of Fracture Nonunion (FNU): A Systematic Review. Pharmacogenomics and personalized medicine 2023 6 16 569-575. Mir Sadat-Ali, Hussain K Al-Omar, Khalid W AlTabash, Ammar K AlOmran, Dakheel A AlDakheel, Hasan N AlSay |
Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology 2023 3 . Tamura Ryota, Iwanami Akio, Ohara Kentaro, Nishimoto Masaaki, Pareira Eriel Sandika, Miwa Tomoru, Tsuzaki Naoko, Kuranari Yuki, Morimoto Yukina, Toda Masahiro, Okano Hideyuki, Nakamura Masaya, Yoshida Kazunari, Sasaki Hika |
ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes. Molecular oncology 2023 3 . Chen Jessica W, Jacot William, Cortés Javier, Krop Ian E, Dent Susan, Harbeck Nadia, De Laurentiis Michelino, Diéras Véronique, Im Young-Hyuck, Stout Thomas J, Schimmoller Frauke, Savage Heidi M, Hutchinson Katherine E, Wilson Timothy |
Rare and Common Variants in GALNT3 May Affect Bone Mass Independently of Phosphate Metabolism. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2023 2 . Hassan Neelam, Gregson Celia L, Tang Haotian, van der Kamp Marc, Leo Paul, McInerney-Leo Aideen M, Zheng Jie, Brandi Maria Luisa, Tang Jonathan C Y, Fraser William, Stone Michael D, Grundberg Elin, , Brown Matthew A, Duncan Emma L, Tobias Jonathan |
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Acta neuropathologica 2023 12 147 (1): 2. Lucie Auffret, Yassine Ajlil, Arnault Tauziède-Espariat, Thomas Kergrohen, Chloé Puiseux, Laurent Riffaud, Pascale Blouin, Anne-Isabelle Bertozzi, Pierre Leblond, Klas Blomgren, Sébastien Froelich, Alberto Picca, Mehdi Touat, Marc Sanson, Kévin Beccaria, Thomas Blauwblomme, Volodia Dangouloff-Ros, Nathalie Boddaert, Pascale Varlet, Marie-Anne Debily, Jacques Grill, David Cast |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Non-Lobular Invasive Breast Carcinomas with Bi-Allelic Pathogenic CDH1 Somatic Alterations: a Histologic, Immunophenotypic and Genomic Characterization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 11 100375. Fatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, Edaise M da Silva, Anne Grabenstetter, Sahar Jalali, Andrea M Gazzo, Higinio Dopeso, Antonio Marra, David N Brown, Dara S Ross, Diana Mandelker, Pedram Razavi, Sarat Chandarlapaty, Hannah Y Wen, Edi Brogi, Hong Zhang, Britta Weigelt, Fresia Pareja, Jorge S Reis-Fil |
How human genetic context can inform pathogenicity classification: FGFR1 variation in idiopathic hypogonadotropic hypogonadism. Human genetics 2023 10 . Wanxue Xu, Lacey Plummer, Stephanie B Seminara, Ravikumar Balasubramanian, Margaret F Lippinco |
The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
Whole-exome sequencing of rectal neuroendocrine tumors. Endocrine-related cancer 2023 1 . Li Yuanliang, Guo Yiying, Cheng Zixuan, Tian Chao, Chen Yingying, Chen Ruao, Yu Fuhuan, Shi Yanfen, Su Fei, Zhao Shuhua, Wang Zhizheng, Luo Jie, Tan Huangyi |
Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
Clinical manifestations and spermatogenesis outcomes in Chinese patients with congenital hypogonadotropic hypogonadism caused by inherited or de novo FGFR1 mutations. Asian journal of andrology 2024 1 . Yu-Fan Yang, Hai-Lu Ma, Xi Wang, Min Nie, Jiang-Feng Mao, Xue-Yan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: